Future of CRISPR (base & prime) and epigenome editing (Interview with Prof David R. Liu)

 

Excellent interview with David Liu of Harvard, which gives an overview of key innovations in gene editing since the discovery of CRISPR. 

Labs all around the world are busy building new tools and libraries for gene editing, with dramatic progress since CRISPR was first discovered less than 10 years ago.

Liu is optimistic about clinical applications over the next 10 years. He does not discuss germline editing (i.e., of embryos) but one can readily imagine how these advances in technology might be applied there.